TRGT Share Price

Open 1.35 Change Price %
High 1.35 1 Day -0.68 -41.46
Low 0.82 1 Week 0.00 0.00
Close 0.96 1 Month 0.00 0.00
Volume 197793 1 Year 0.00 0.00
52 Week High 112.00
52 Week Low 0.00
TRGT Important Levels
Resistance 2 1.45
Resistance 1 1.25
Pivot 1.04
Support 1 0.67
Support 2 0.47
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
ETRM 0.07 40.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
MU 20.66 1.08%
MU 20.66 1.08%
More..
NASDAQ USA Top Gainers Stocks
SSH 0.58 176.19%
SSH 0.58 176.19%
SSH 0.58 176.19%
IRG 0.43 72.00%
IRG 0.43 72.00%
IRG 0.43 72.00%
IRG 0.43 72.00%
IRG 0.43 72.00%
MBLX 0.51 64.52%
COOL 5.17 63.61%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
SHIP 1.20 -45.45%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

Targacept, Inc. (NASDAQ: TRGT)

TRGT Technical Analysis 5
As on 20th Aug 2015 TRGT Share Price closed @ 0.96 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.54 & Strong Sell for SHORT-TERM with Stoploss of 2.60 we also expect STOCK to react on Following IMPORTANT LEVELS.
TRGT Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
TRGT Other Details
Segment EQ
Market Capital 139070800.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.targacept.com
TRGT Address
TRGT
100 North Main Street
Suite 1510
Winston-Salem, NC 27101
United States
Phone: 336-480-2100
Fax: 336-480-2107
TRGT Latest News
Penny Stock in the News: Update On Catalyst Biosciences, Inc. (:CBIO)   Duncan Research   - 08th Dec 16
Is This the Next Wonder Stock? Investors Keen on Catalyst Biosciences, Inc ...   Duncan Research   - 08th Dec 16
CATALYST BIOSCIENCES, INC. (NASDAQ:CBIO) Files An 8-K Notice of Delisting or ...   Market Exclusive   - 03rd Dec 16
Catalyst Biosciences ending future research, eliminating half of workforce   Winston-Salem Journal   - 08th Sep 16
Catalyst Biosciences to Present at Ophthalmology Innovation Summit   GlobeNewswire (press release)   - 03rd Aug 16
Catalyst Biosciences Announces Appointments of Chief Medical Officer and Vice ...   GlobeNewswire (press release)   - 18th Apr 16
Catalyst Biosciences Completes Merger With Targacept and Creates a Protease ...   GlobeNewswire (press release)   - 21st Aug 15
Targacept to merge with Catalyst Biosciences   Triad Business Journal   - 06th Mar 15
Catalyst Biosciences And Isu Abxis Announce Collaboration To Develop Next ...   PR Newswire (press release)   - 09th Oct 13
News Catalyst Biosciences Inc.CBIO   Wall Street Journal   - 07th Aug 11
Interactive Technical Analysis Chart Targacept, Inc. ( TRGT NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Targacept, Inc.
TRGT Business Profile
Targacept, Inc. is a biopharmaceutical company. The Company is engaged in the design, discovery and development of NNR Therapeutics for the treatment of diseases and disorders of the nervous system. The Company's NNR Therapeutics target neuronal nicotinic receptors (NNRs). As of December 31, 2011, the Company had multiple clinical-stage product candidates and preclinical programs in areas. The Company's drug discovery activities utilize computer-based molecular design methodologies and biological and chemical data for a library of diverse compounds developed and collected. The Company refers to these technologies collectively as Pentad. Its clinical-stage product candidates include TC-5214, TC-5619, TC-6987, AZD3480 (TC-1734), AZD1446 (TC-6683), TC-6499 and TC-6987.